HSBC analyst Jeremy Fialko downgraded Haleon (HLN) to Hold from Buy with a 420 GBp price target See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Berenberg analyst Bethan Davies raised the firm’s price target on Haleon (HLN) to 457 GBp from 456 GBp and keeps a Buy rating on the shares. See what stocks are receiving Strong Buy ratings from ...

Shares of HLN opened at $10.45 on Wednesday. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a 50-day moving average price of $9.66 and a two-hundred day moving ...

In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has successfully exported Centrum—a ...

Shares of Haleon plc (NYSE:HLN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the stock, MarketBeat.com reports.

This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease ...

Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing organization in Sri Lanka, which commenced manufacturing in 1956 with the flagship ...

Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.61% to 8,809.74.

From left: Satheeskanth Sithambaram (Snr. Manager – Medical Marketing, Haleon Lanka), Harsha Ratnayake (Marketing Lead – Haleon Lanka), Manjula Weerakoon (Commercial Lead – Sri Lanka ...

Haleon PLC delivered strong annual results but a surprise second-half weighting to guidance could see the stock suffe ... Subscribe now to see this Premium News article from Alliance News ...